Semaglutide API is a glucagon-like peptide-1 (GLP-1) analog produced via recombinant DNA technology, typically expressed in Pichia pastoris yeast. It consists of 31 amino acids modified with a fatty acid side chain to prolong half-life and enhance stability.

CAS: 910463-68-2
Key Features:

• High Purity: Manufactured to meet pharmacopeial standards (EP/CP), ensuring minimal impurities.
• Bioactivity: Acts as a GLP-1 receptor agonist, stimulating insulin secretion, suppressing glucagon, and promoting satiety.
 • Applications: Treats type 2 diabetes mellitus, obesity, and reduces cardiovascular risk in eligible patients.

• Quality Assurance: Produced under cGMP; tested for identity, potency, sterility, endotoxins, and residual solvents.

Storage: Stable at 2–8°C; protect from light and freezing.

This API is pivotal in therapies for metabolic disorders, offering sustained glycemic control and weight management with robust safety and regulatory compliance.